IL11Rα Ab treatment did not alter IL11 mRNA, but led to a trend in increased GP130 mRNA, while IL11Rα Ab and doxorubicin treatment significantly increased IL11Rα (p < 0.05) in subcutaneous AN3CA tumours (Figure 4C–4E). The gene discussed is IL11; the disease is neoplasm.